Endocrinologia Clínica (Lúcio Vilar) - 6 Edição_Parte387

Prévia do material em texto

35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
Partsch CJ, Japing I, Siebert R et al. Central precocious puberty in girls with Williams syndrome. J Pediatr. 2002; 141:441-
4.
Young C, Wang PJ, Tsai WY et al. Precocious puberty in a case with probable Angelman syndrome. Brain Dev. 1994;
16:249-52.
Habiby R, Silverman B, Listerenick R et al. Precocious puberty in children with neurofibromatosis type I. J Pediatr. 1995;
126:364-7.
de Brito VN, Latronico AC, Arnhold IJ et al. Treatment of gonadotropin dependent precocious puberty due to hypothalamic
hamartoma with gonadotropina releasing hormone agonist depot. Arch Dis Child. 1999; 80:231-4.
Jung H, Carmel P, Schwartz MS et al. Some hypothalamic hamartomas contain transforming growth factor alpha, a puberty-
inducing growth factor, but not luteinizing hormone-releasing hormone neurons. J Clin Endocrinol Metab. 1999;
84:4695-701.
Jung H, Neumaier Probst E, Hauffa BP et al. Association of morphological characteristics with precocious puberty and/or
gelastic seizures in hypothalamic hamartoma. J Clin Endocrinol Metab. 2003; 88:4590-5.
Cukier P, Castro LH, Banaskiwitz N et al. The benign spectrum of hypothalamic hamartomas: infrequent epilepsy and
normal cognition in patients presenting with central precocious puberty. Seizure. 2013; 22:28-32.
Mouritsen A, Aksglaede L, Sorensen K et al. Hypothesis: exposure to endocrine-disrupting chemicals may interfere with
timing of puberty. Int J Androl. 2010; 33:346-59.
 Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970; 45:13-23.
Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969; 44:291-303.
Brito VN, Batista MC, Borges MF et al. Diagnostic value of fluorometric assays in the evaluation of precocious puberty. J
Clin Endocrinol Metab. 1999; 84:3539-44.
Brito VN, Latronico AC, Arnhold IJ et al. A single luteinizing hormone determination 2 hours after depot leuprolide is
useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls. J Clin Endocrinol Metab. 2004;
89:4338-42.
Resende EA, Lara BH, Reis JD et al. Assessment of basal and gonadotropin-releasing hormone-stimulated gonadotropins by
immunochemiluminometric and immunofluorometric assays in normal children. J Clin Endocrinol Metab. 2007;
92:1424-9.
Neely EK, Hintz RL, Wilson DM et al. Normal ranges for immunochemiluminometric gonadotropin assays. J Pediatr. 1995;
127:40-6.
Freire AV, Gryngarten MG, Ballerini MG et al. Assessment of estradiol response after depot Triptorelin administration in
girls with central precocious puberty. Horm Res Paediatr. 2015 Dec 17. [Epub ahead of print.]
Badouraki M, Christoforidis A, Economou I et al. Evaluation of pelvic ultrasonography in the diagnosis and differentiation
of various forms of sexual precocity in girls. Ultrasound Obstet Gynecol. 2008; 32:819-27.
Carel JC, Eugster EA, Rogol A et al. Consensus statement on the use of gonadotropin-releasing hormone analogs in
children. Pediatrics. 2009; 123:e752-62.
Mogensen SS, Aksglaede L, Mouritsen A et al. Pathological and incidental findings on brain MRI in a single-center study of
229 consecutive girls with early or precocious puberty. PLoS One. 2012; 7:e29829.
Heger S, Sippell WG, Partsch CJ. Gonadotropin-releasing hormone analogue treatment for precocious puberty. Twenty
years of experience. Endocr Dev. 2005; 8:94-125.
Brito VN, Latronico AC, Cukier P et al. Factors determining normal adult height in girls with gonadotropin-dependent
precocious puberty treated with depot gonadotropin-releasing hormone analogs. J Clin Endocrinol Metab. 2008; 93:2662-
9.
Carel JC, Lahlou N, Jaramillo O et al. Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-
month depot (11.25 mg). J Clin Endocrinol Metab. 2002; 87:4111-6.
Carel JC, Blumberg J, Seymour C et al. Three-month sustained-release triptorelin (11.25 mg) in the treatment of central
precocious puberty. Eur J Endocrinol. 2006; 154:119-24.
Fuld K, Chi C, Neely EK. A randomized trial of 1- and 3-month depot leuprolide doses in the treatment of central
precocious puberty. J Pediatr. 2011; 159:982-7.
Mericq V, Lammoglia JJ, Unanue N et al. Comparison of three doses of leuprolide acetate in the treatment of central
precocious puberty: preliminary results. Clin Endocrinol (Oxf). 2009; 71:686-90.
Eugster EA, Clarke W, Kletter GB et al. Efficacy and safety of histrelina subdermal implant in children with central
precocious puberty: a multicenter trial. J Clin Endocrinol Metab. 2007; 92:1697-704.
Badaru A, Wilson DM, Bachrach LK et al. Sequential comparisons of one-month and three-month depot leuprolide
regimens in central precocious puberty. J Clin Endocrinol Metab. 2006; 91:1862-7.
	Endocrinologia Clínica (Lúcio Vilar) - 6ª Edição